ILMN – Illumina, Inc.

Illumina, Inc.

ILMN

$160.03

Name : Illumina, Inc.

Sector : Healthcare

Industry: Diagnostics & Research

Mark. Cap: $24,212,539,392.00

EPSttm : 5.51

Illumina, Inc.

$160.03

1.26%

$1.99

ILMN — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

4.97

Margin Of Safety %

-23

Put/Call OI Ratio

0.42

EPS Next Q Diff

0.22

EPS Last/This Y

-0.24

EPS This/Next Y

0.7

Price

160.01

Target Price

144.35

Analyst Recom

2.41

Performance Q

30.8

Upside

-24.3%

Beta

1.49

Ticker: ILMN

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-05-11	ILMN	142.39	0.58	0.22	21137
2026-05-12	ILMN	145.77	0.58	0.15	21329
2026-05-13	ILMN	144.92	0.55	0.09	22622
2026-05-14	ILMN	143.17	0.54	0.23	23090
2026-05-15	ILMN	142.61	0.47	0.51	26264
2026-05-18	ILMN	141.38	0.39	0.17	20359
2026-05-19	ILMN	141.7	0.39	0.36	20466
2026-05-20	ILMN	141.89	0.40	0.55	20557
2026-05-21	ILMN	144.8	0.40	0.25	20666
2026-05-22	ILMN	144.43	0.40	0.21	20797
2026-05-26	ILMN	145.25	0.40	0.13	20786
2026-05-27	ILMN	150.2	0.40	0.28	20701
2026-05-28	ILMN	158.72	0.41	0.14	20626
2026-05-29	ILMN	162.92	0.40	0.12	20979
2026-06-02	ILMN	162.62	0.41	0.48	21593
2026-06-03	ILMN	171.04	0.41	0.18	21650
2026-06-04	ILMN	168.04	0.41	0.29	21906
2026-06-05	ILMN	162.3	0.41	0.21	22087
2026-06-08	ILMN	158.05	0.41	0.19	22089
2026-06-09	ILMN	160	0.42	0.17	22064
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-05-11	ILMN	142.46	2.7	-131.6	5.22
2026-05-12	ILMN	145.71	2.7	-114.0	5.22
2026-05-13	ILMN	145.00	2.7	-140.3	5.22
2026-05-14	ILMN	143.18	2.7	-147.7	5.22
2026-05-15	ILMN	142.57	2.7	-140.1	5.22
2026-05-18	ILMN	141.52	2.8	-142.5	5.23
2026-05-19	ILMN	141.68	2.8	-134.5	5.23
2026-05-20	ILMN	141.87	2.8	-134.3	5.23
2026-05-21	ILMN	144.81	2.8	-116.0	5.23
2026-05-22	ILMN	144.42	2.8	-138.4	5.23
2026-05-26	ILMN	145.22	2.8	-130.2	5.23
2026-05-27	ILMN	150.17	2.8	-102.8	5.23
2026-05-28	ILMN	158.71	2.8	-80.7	5.23
2026-05-29	ILMN	162.88	2.8	-110.2	5.23
2026-06-01	ILMN	164.45	2.8	-126.8	5.23
2026-06-02	ILMN	162.28	2.8	-148.4	5.23
2026-06-03	ILMN	171.04	2.8	-84.9	5.23
2026-06-04	ILMN	168.05	2.8	-152.6	5.23
2026-06-05	ILMN	162.32	2.9	-168.9	5.23
2026-06-08	ILMN	158.08	2.9	-161.0	5.23
2026-06-09	ILMN	160.01	2.9	-123.5	5.23
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-05-11	ILMN	-0.12	1.43	4.88
2026-05-12	ILMN	-0.12	1.43	4.45
2026-05-13	ILMN	-0.12	1.43	4.45
2026-05-14	ILMN	-0.12	1.43	4.45
2026-05-15	ILMN	-7.39	1.43	4.45
2026-05-18	ILMN	-7.39	2.95	4.45
2026-05-19	ILMN	-7.37	2.95	4.34
2026-05-20	ILMN	-45.96	2.95	4.34
2026-05-21	ILMN	-45.96	2.95	4.34
2026-05-22	ILMN	-45.96	2.95	4.34
2026-05-26	ILMN	-45.96	-0.86	4.34
2026-05-27	ILMN	-45.96	-0.86	4.34
2026-05-28	ILMN	-45.96	-0.86	4.97
2026-05-29	ILMN	-45.96	-0.86	4.97
2026-06-02	ILMN	-71.14	-1.78	4.97
2026-06-03	ILMN	-71.14	-1.78	4.97
2026-06-04	ILMN	-71.14	-1.78	4.97
2026-06-05	ILMN	-71.15	-1.78	4.97
2026-06-08	ILMN	-71.15	-1.26	4.97
2026-06-09	ILMN	-71.15	-1.26	4.97
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

1.15

Avg. EPS Est. Current Quarter

1.22

Avg. EPS Est. Next Quarter

1.37

Insider Transactions

-71.15

Institutional Transactions

-1.26

Beta

1.49

Average Sales Estimate Current Quarter

1130

Average Sales Estimate Next Quarter

1143

Fair Value

123.21

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

68.7

Max Drawdown 5-Year %

-86.2

Target Price

144.35

P/E

29.04

Forward P/E

27.09

PEG

2.29

P/S

5.51

P/B

9.09

P/Free Cash Flow

24.86

EPS

5.51

Average EPS Est. Cur. Y

5.23

EPS Next Y. (Est.)

5.92

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

19.43

Relative Volume

0.87

Return on Equity vs Sector %

4.4

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

0.03

EBIT Estimation

-123.5

◆ ILMN Healthcare

$160.03

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

0/20

Pullback

8/25

Volume

4/15

Valuation

6/20

TP/AR

3/10

Options

7/10

RSI

61.1

Range 1M

57%

Sup Dist

2.9%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

6/25

Growth

12/30

Estimates

8/20

Inst/Vol

4/15

Options

9/10

EPS Yr

7.9%

EPS NY

13.2%

52W%

81.7%

💎

Long-Term Value

Quality companies, undervalued

WEAK

🔴 SELL -18.2% upside

Quality

27/30

Valuation

2/30

Growth

11/25

Stability

5/10

LT Trend

1/5

Upside

-18.2%

Quality

MoS

-23%

Illumina, Inc.

Sector: Healthcare

Industry: Diagnostics & Research

Employees: 8600

Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers, as well as through life-science distributors. The company has a collaboration with Labcorp Holdings Inc. for the development of oncology treatments through applications of sequencing solutions across the healthcare ecosystem; and strategic collaboration with Integrated DNA Technologies to enable a DRAGEN, secondary analysis pipeline for IDT xGena, FFPE and cfDNA next generation sequencing (NGS) library preparation with custom panels, delivering an integrated, end-to-end solution for somatic oncology research. It also has a data partnership with Center for Data-Driven Discovery in Biomedicine to advance research in pediatric cancer and rare disease. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California.

ILMN

Latest News

—

Caricamento notizie per ILMN…

stock quote shares ILMN – Illumina, Inc. Stock Price stock today

news today ILMN – Illumina, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch ILMN – Illumina, Inc. yahoo finance google finance

stock history ILMN – Illumina, Inc. invest stock market

stock prices ILMN premarket after hours

ticker ILMN fair value insiders trading

ILMN – Illumina, Inc.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: ILMN

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y